Physician profile
Marc E Lynch
NPI 1760488621
$114,308.87
in general payments reported to CMS, 2019-2025
46 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $9,086 · 2021: $5,295 · 2022: $6,455 · 2023: $24K · 2024: $40K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $23K · Food and Beverage: $13K · Travel and Lodging: $6,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,250.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $23,073.00 |
| Food and Beverage | $12,880.37 |
| Travel and Lodging | $6,232.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $51,314.55 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Biotronik Nro, INC. | $28,501.96 | 2023-2025 | Prospera, Biotronik |
| Abbott Laboratories | $23,551.30 | 2019-2025 | Proclaim, Eterna |
| Vertiflex, INC. | $2,057.42 | 2019 | |
| Boston Scientific Corporation | $1,756.37 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System |
| Nevro Corp. | $1,228.83 | 2019-2024 | Senza |
| Abbvie INC. | $924.90 | 2022-2025 | |
| Nalu Medical, INC. | $849.00 | 2021-2025 | Nalu Neurostimulation System |
| Painteq LLC | $652.33 | 2022-2024 | Painteq |
| Allergan, INC. | $352.39 | 2019-2022 | |
| Spinal Simplicity, LLC | $274.46 | 2021-2025 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $245.28 | 2023-2025 | Evoke Scs, Evoke |
| Merz Pharmaceuticals, LLC | $191.05 | 2022-2025 | Xeomin |
| Si-Bone, INC. | $183.62 | 2019-2025 | |
| Virtus Pharmaceuticals LLC | $167.30 | 2023-2025 | Levorphanol Tartrate |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.